These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21356164)

  • 61. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification.
    Ginghina O; Hudita A; Zamfir M; Spanu A; Mardare M; Bondoc I; Buburuzan L; Georgescu SE; Costache M; Negrei C; Nitipir C; Galateanu B
    Front Oncol; 2022; 12():856575. PubMed ID: 35356214
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
    Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes.
    Shek D; Akhuba L; Carlino MS; Nagrial A; Moujaber T; Read SA; Gao B; Ahlenstiel G
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
    Malki A; ElRuz RA; Gupta I; Allouch A; Vranic S; Al Moustafa AE
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374459
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comprehensive review of targeted therapy for colorectal cancer.
    Xie YH; Chen YX; Fang JY
    Signal Transduct Target Ther; 2020 Mar; 5(1):22. PubMed ID: 32296018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatic metastasis from colorectal cancer.
    Kow AWC
    J Gastrointest Oncol; 2019 Dec; 10(6):1274-1298. PubMed ID: 31949948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up.
    Caraglia M; Correale P; Giannicola R; Staropoli N; Botta C; Pastina P; Nesci A; Caporlingua N; Francini E; Ridolfi L; Mini E; Roviello G; Ciliberto D; Agostino RM; Strangio A; Azzarello D; Nardone V; Falzea A; Cappabianca S; Bocchetti M; D'Arrigo G; Tripepi G; Tassone P; Addeo R; Giordano A; Pirtoli L; Francini G; Tagliaferri P
    Front Oncol; 2019; 9():1102. PubMed ID: 31781481
    [No Abstract]   [Full Text] [Related]  

  • 68. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates.
    Akbarzadeh Khiavi M; Safary A; Somi MH
    Bioimpacts; 2019; 9(3):123-127. PubMed ID: 31508327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.
    Chen CL; Chen CK; Ho CL; Chi WM; Yeh CH; Hu SP; Friebe P; Palmer S; Huang CS
    Mol Diagn Ther; 2019 Oct; 23(5):645-656. PubMed ID: 31347028
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis.
    Amawi H; Hussein NA; Ashby CR; Alnafisah R; Sanglard LM; Manivannan E; Karthikeyan C; Trivedi P; Eisenmann KM; Robey RW; Tiwari AK
    Front Pharmacol; 2018; 9():520. PubMed ID: 29875662
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth.
    Uemura T; Kametaka S; Waguri S
    Sci Rep; 2018 Jan; 8(1):1368. PubMed ID: 29358589
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DNA terminal structure-mediated enzymatic reaction for ultra-sensitive discrimination of single nucleotide variations in circulating cell-free DNA.
    Wu T; Chen W; Yang Z; Tan H; Wang J; Xiao X; Li M; Zhao M
    Nucleic Acids Res; 2018 Feb; 46(4):e24. PubMed ID: 29190359
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy.
    He H; Markoutsa E; Zhan Y; Zhang J; Xu P
    Acta Biomater; 2017 Sep; 59():181-191. PubMed ID: 28688985
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Li Q; Parchur AK; Zhou A
    Sci Technol Adv Mater; 2016; 17(1):346-360. PubMed ID: 27877887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients.
    Jing C; Jin YH; You Z; Qiong Q; Jun Z
    Oncotarget; 2016 Aug; 7(34):55890-55899. PubMed ID: 27344184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
    Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
    J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials.
    Koukakis R; Gatta F; Hechmati G; Siena S
    Qual Life Res; 2016 Oct; 25(10):2645-2656. PubMed ID: 27083443
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recent developments in receptor tyrosine kinases targeted anticancer therapy.
    Raval SH; Singh RD; Joshi DV; Patel HB; Mody SK
    Vet World; 2016 Jan; 9(1):80-90. PubMed ID: 27051190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.
    Zhang F; Yang X; Li L; Sun L; Wang BO; Yu X
    Oncol Lett; 2016 Jan; 11(1):173-181. PubMed ID: 26870185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study.
    Turhal NS; Savaş B; Çoşkun Ö; Baş E; Karabulut B; Nart D; Korkmaz T; Yavuzer D; Demir G; Doğusoy G; Artaç M
    Mol Clin Oncol; 2015 Nov; 3(6):1275-1279. PubMed ID: 26807232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.